Unilesoinal cutaneous T-cell lymphoma: Clinical features, therapy, and follow-up of 10 patients with a treatment-responsive mycosis fungoides variant

Journal of the American Academy of Dermatology

Volumn 42, Issue 2 I, 2000, Pages 283-285

  Heald, Peter W ^a,b   Glusac, Earl J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b 500 LCI ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MALE; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; SKIN MANIFESTATION; T CELL LYMPHOMA; TREATMENT OUTCOME; AGED; CUTANEOUS T CELL LYMPHOMA; MIDDLE AGED; PATHOLOGY; RECURRENT DISEASE; SKIN TUMOR; TOPICAL DRUG ADMINISTRATION;

ALKYLATING AGENT; CARMUSTINE;

ADMINISTRATION, TOPICAL; ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; CARMUSTINE; FEMALE; HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; RECURRENCE; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 0034133913     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(00)90140-3     Document Type: Article

References (11)

1. Heald PW, Yan SL, Edelson RL, Tigelaar R, Picker LJ. Skin selective lymphocyte homing mechanisms in the pathogenesis of leukemic cutaneous T-cell lymphoma. J Invest Dermatol 1993;101:222-6.
2. Heald PW, Edelson RL. Cutaneous lymphomas and related disorders. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, editors. Dermatology in general medicine. New York: McGraw-Hill; 1993. p. 1285-306.
3. Willemze R, Beljaards RC, Meijer CJLM. Classification of primary cutaneous T-cell lymphomas. Histopathology 1994;24:405-15.
4. Lever WF. Localized mycosis fungoides with prominent epidermotropism:Woringer-Kolopp Disease. Arch Dermatol 1977;113:1254-6.
5. Mandojana RM, Helwig EB. Localized epidermotropic reticulosis (Woringer-Kolopp disease): a clinicopathologic study of 15 new cases. J Am Acad Dermatol 1983;8:813-29.
6. Burns MK, Chan LS, Cooper KD. Woringer-Kolopp disease (localized pagetoid reticulosis) of unilesional mycosis fungoides? An analysis of eight cases with benign disease. Arch Dermatol 1995;131:325-9.
7. Oliver GF, Winkelmann RK. Unilesional mycosis fungoides: a distinct entity. J Am Acad Dermatol 1989;20:63-70.
8. Zackheim HS, Epstein EH, Crain WR. Topical carmustine (BCNU) for cutaneous T-cell lymphoma: a 15-year experience in 143 patients. J Am Acad Dermatol 1990;22:802-10.
9. Smoller BR, Bishop K, Glusac E, Kim YH, Hendrickson M. Reassessment of histologic parameters in the diagnosis of mycosis fungoides. Am J Surg Pathol 1995;19:1423-30.
10. Berger CL, Wang N, Christensen I, Longley J, Heald P, Edelson RL. The immune response to class I associated tumor-specific cutaneous T-cell lymphoma antigens. J Invest Dermatol 1996;107: 392-7.
11. Hoppe RT, Medeiros LJ, Warnke RA, Wood GS. CD8-positive tumor infiltrating lymphocytes influence the long-term survival of patients with mycosis fungoides. J Am Acad Dermatol 1995;32:448-55.